Related Experiment Video
Updated: May 11, 2025

09:16
Analysis of RNA Processing Reactions Using Cell Free Systems: 3' End Cleavage of Pre-mRNA Substrates in vitro
Published on: May 3, 2014
12.8K
Mechanistic insights into RNA cleavage by human Argonaute2-siRNA complex
Zhenzhen Li1,2,3,4, Qikui Xu1,3,4,5, Yan Zhang2,3,4
1Fudan University, Shanghai, China.
Cell Research
|April 16, 2025
Summary
Argonaute (AGO) proteins use small interfering RNAs (siRNAs) to silence target RNAs. This study reveals how AGO-siRNA complexes undergo conformational changes to achieve efficient target RNA cleavage, overcoming structural limitations.
Area of Science:
- Molecular Biology
- RNA Interference
- Structural Biology
Background:
- Argonaute (AGO) proteins, guided by small interfering RNAs (siRNAs), cleave target RNAs for gene silencing.
- AGO proteins possess a narrow binding channel limiting extensive guide-target base pairing, posing a challenge for efficient target recognition and cleavage.
Purpose of the Study:
- To elucidate the structural mechanisms by which AGO-siRNA complexes achieve target RNA cleavage despite channel limitations.
- To investigate the conformational dynamics of human AGO-siRNA complexes during target binding and catalytic activation.
Main Methods:
- Cryo-electron microscopy (cryo-EM) was used to visualize human AGO-siRNA complexes bound to target RNAs of varying lengths.
- Analysis of structural transitions and domain movements within the AGO complex during target engagement.
Main Results:
- Stepwise conformational changes were observed, initiated by PAZ domain opening and PIWI-L1-N domain repositioning for siRNA-target duplex capture.
- Further base pairing induced PIWI-L1-N domain movement for catalytic activation and a "uni-lobed" architecture.
- The uni-lobed AGO structure facilitates extensive target interaction within the catalytic site, distinct from PIWI proteins.
Conclusions:
- The study reveals a dynamic, stepwise mechanism for AGO-mediated target RNA cleavage.
- Structural insights highlight how AGO complexes overcome binding channel constraints for efficient catalysis.
- Findings illuminate distinct functional differences between AGO and PIWI Argonautes in RNA cleavage.
Related Concept Videos
siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
RNA Editing
8.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.8K
RNA Interference
25.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.8K
Ribozymes
11.0K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
11.0K
Conservation of Protein Domains Over Different Proteins
10.6K
Protein domains are small structurally independent units that are part of a single amino acid chain. Although these domains are often structurally independent, they may rely on synergistic effects to perform their functions as part of a larger protein. Protein domains may be conserved within the same organism, as well as across different organisms.
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
10.6K

